Barclays’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $498K | Sell |
|
|||||
|
2025
Q2 | $362K | Buy |
|
|||||
|
2025
Q1 | $196K | Sell |
|
|||||
|
2024
Q4 | $262K | Buy |
|
|||||
|
2024
Q3 | $285K | Buy |
|
|||||
|
2024
Q2 | $90K | Sell |
|
|||||
|
2024
Q1 | $246K | Sell |
|
|||||
|
2023
Q4 | $388K | Buy |
|
|||||
|
2023
Q3 | $193K | Sell |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $1.06M | Sell |
|
|||||
|
2022
Q4 | $2.37M | Buy |
|
|||||
|
2022
Q3 | $2.35M | Buy |
|
|||||
|
2022
Q2 | $274K | Sell |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $1.87M | Buy |
|
|||||
|
2021
Q3 | $1.29M | Buy |
|
|||||
|
2021
Q2 | $495K | Sell |
|
|||||
|
2021
Q1 | $1.16M | Sell |
|
|||||
|
2020
Q4 | $1.04M | Sell |
|
|||||
|
2020
Q3 | $1.2M | Buy |
|
|||||
|
2020
Q2 | $904K | Buy |
|
|||||
|
2020
Q1 | $759K | Sell |
|
|||||
|
2019
Q4 | $2.99M | Buy |
|
|||||
|
2019
Q3 | $2.18M | Sell |
|
|||||
|
2019
Q2 | $3.09M | Sell |
|
|||||
|
2019
Q1 | $5.37M | Buy |
|
|||||
|
2018
Q4 | $795K | Sell |
|
|||||
|
2018
Q3 | $2.44M | Buy |
|
|||||
|
2018
Q2 | $632K | Sell |
|
|||||
|
2018
Q1 | $654K | Sell |
|
|||||
|
2017
Q4 | $1.58M | Buy |
|
|||||
|
2017
Q3 | $1.25M | Sell |
|
|||||
|
2017
Q2 | $1.08M | Sell |
|
|||||
|
2017
Q1 | $1.82M | Buy |
|
|||||
|
2016
Q4 | $365K | Buy |
|
|||||
|
2016
Q3 | $21K | Buy |
|
|||||
|
2016
Q2 | $9K | Sell |
|
|||||
|
2016
Q1 | $65K | Buy |
|
|||||
|
2015
Q4 | $13K | Sell |
|
|||||
|
2015
Q3 | $177K | Buy |
|
|||||
|
2015
Q2 | $17K | Sell |
|
|||||
|
2015
Q1 | $22K | Sell |
|
|||||
|
2014
Q4 | $43K | Sell |
|
|||||
|
2014
Q3 | $1.5M | Sell |
|
|||||
|
2014
Q2 | $2.96M | Sell |
|
|||||
|
2014
Q1 | $3.14M | Sell |
|
|||||
|
2013
Q4 | $4.13M | Sell |
|
|||||
|
2013
Q3 | $4.56M | Buy |
|
|||||
|
2013
Q2 | $3.18M | Buy |
|